Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Sell
8,295
-363
-4% -$124K 0.04% 413
2026
Q1
$3.05M Buy
8,658
+2,540
+42% +$905K 0.05% 363
2025
Q4
$2M Buy
6,118
+851
+16% +$270K 0.04% 393
2025
Q3
$1.49M Buy
5,267
+46
+0.9% +$13.3K 0.03% 439
2025
Q2
$1.46M Sell
5,221
-48
-0.9% -$13.6K 0.04% 411
2025
Q1
$1.64M Sell
5,269
-88
-2% -$26K 0.05% 347
2024
Q4
$1.4M Sell
5,357
-231
-4% -$68.5K 0.04% 385
2024
Q3
$1.8M Buy
5,588
+483
+9% +$158K 0.05% 295
2024
Q2
$1.59M Buy
5,105
+524
+11% +$154K 0.05% 299
2024
Q1
$1.3M Buy
4,581
+125
+3% +$36.6K 0.05% 349
2023
Q4
$1.28M Buy
4,456
+308
+7% +$83.9K 0.05% 307
2023
Q3
$1.11M Buy
4,148
+25
+0.6% +$6.24K 0.06% 304
2023
Q2
$915K Sell
4,123
-690
-14% -$160K 0.05% 359
2023
Q1
$1.16M Sell
4,813
-364
-7% -$89.4K 0.06% 284
2022
Q4
$1.36M Sell
5,177
-118
-2% -$31.6K 0.08% 238
2022
Q3
$1.29M Hold
5,295
– – 0.09% 230
2022
Q2
$1.29M Buy
+5,295
New +$1.3M 0.09% 230
2021
Q4
$1.18M Sell
5,262
-5,829
-53% -$1.23M 0.07% 265
2021
Q3
$2.36M Buy
11,091
+1,596
+17% +$367K 0.08% 238
2021
Q2
$2.31M Buy
9,495
+737
+8% +$181K 0.07% 249
2021
Q1
$2.18M Buy
+8,758
New +$2.09M 0.08% 233

Other funds holding AMGN

Harbour Investments's AMGN Position: Q2 2026 in Review

Harbour Investments reduced its Amgen (AMGN) stake by 4.2% in Q2 2026, selling an estimated $124K and leaving 8,295 shares worth $3M. The position accounts for 0.04% of the portfolio, ranked #413.

Harbour Investments first reported a position in AMGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.05M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Harbour Investments held 8,295 shares of Amgen worth $3M as of Q2 2026.
  • Harbour Investments sold 363 Amgen shares in Q2 2026, an estimated $124K.
  • Amgen made up 0.04% of Harbour Investments's portfolio in Q2 2026, its #413 holding.
  • Harbour Investments first reported a position in Amgen in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Amgen position peaked at $3.05M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.